Hi all,
I've looked through the forum but I could not find an answer to this.
I'm in the process of establishing a protocol for shelf-life validation of the sterile barrier system and medical device and I was reading through ASTM F1980-21.
In the scope section, I came across this sentence:
I'm not a native speaker, so I'm not sure if I'm interpreting this correctly.
Does it say that I cannot use results of accelerated ageing to provide storage conditions for my packaged device?
If this is the case, how should I establish storage condition?
Any help will be appreciated!
I've looked through the forum but I could not find an answer to this.
I'm in the process of establishing a protocol for shelf-life validation of the sterile barrier system and medical device and I was reading through ASTM F1980-21.
In the scope section, I came across this sentence:
1.7 The data obtained from accelerated aging studies is not to be used as a manner of establishing label storage conditions for sterile barrier systems.
I'm not a native speaker, so I'm not sure if I'm interpreting this correctly.
Does it say that I cannot use results of accelerated ageing to provide storage conditions for my packaged device?
If this is the case, how should I establish storage condition?
Any help will be appreciated!